1224 Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invigorate antitumor immunity in pancreatic cancer
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.